等待开盘 02-03 09:30:00 美东时间
+0.001
+0.30%
Peer-reviewed clinical validation, strengthened balance sheet, and disciplined execution position the Company for 2026SHELTON, Conn., Jan. 13, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. (NASDAQ:INTS) ("Intensity"
01-13 20:51
Peer-reviewed clinical validation, strengthened balance sheet, and disciplined execution position the Company for 2026 SHELTON, Conn., Jan. 13, 2026 /PRNewswire/ -- Intensity Therapeutics, I...
01-13 20:47
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 14.1% to...
01-09 05:06
Intensity Therapeutics, Inc. ("Intensity" or "the Company") (NASDAQ:INTS), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to
2025-12-05 20:31
Intensity Therapeutics shares are trading higher after the company announced tw...
2025-12-04 22:03
Intensity Therapeutics, Inc. ( ($INTS) ) has shared an announcement. On Decembe...
2025-12-04 20:29
Intensity Therapeutics, Inc. ( ($INTS) ) has provided an announcement. On Octob...
2025-11-01 05:18
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - November ...
2025-11-01 03:11
Gainers Alphatec Holdings (NASDAQ:ATEC) shares rose 21.7% to $19.88 during Fri...
2025-10-31 20:10
生物制药公司Intensity Therapeutics,周四公布其转移性或难治性癌症候选药物INT230-6的1/2期临床试验结果后,股价收盘暴涨近395%。
2025-10-31 08:09